Alberta Stroke Program Early CT Score-Time Score Predicts Outcome after Endovascular Therapy in Patients with Acute Ischemic Stroke: A Retrospective Single-Center Study

J Stroke Cerebrovasc Dis. 2018 Apr;27(4):1041-1046. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.007. Epub 2017 Dec 6.

Abstract

Background: Clinical outcomes after successful endovascular therapy in patients with acute ischemic stroke are associated with several factors including onset-to-reperfusion time (ORT), the National Institute of Health Stroke Scale (NIHSS) score, and the Alberta Stroke Program Early CT Score (ASPECTS). The NIHSS-time score, calculated as follows: [NIHSS score] × [onset-to-treatment time (h)] or [NIHSS score] × [ORT (h)], has been reported to predict clinical outcomes after intravenous recombinant tissue plasminogen activator therapy and endovascular therapy for acute stroke. The objective of the current study was to assess whether the combination of the ASPECTS and the ORT can predict the outcomes after endovascular therapy.

Methods: The charts of 117 consecutive ischemic stroke patients with successful reperfusion after endovascular therapy were retrospectively reviewed. We analyzed the association of ORT, ASPECTS, and ASPECTS-time score with clinical outcome. ASPECTS-time score was calculated as follows: [11 - ASPECTS] × [ORT (h)].

Results: Rates of good outcome for patients with ASPECTS-time scores of tertile values, scores 5.67 or less, scores greater than 5.67 to 10.40 or less, and scores greater than 10.40, were 66.7%, 56.4%, and 33.3%, respectively (P < .05). Ordinal logistic regression analysis showed that the ASPECTS-time score (per category increase) was an independent predictor for better outcome (common odds ratio: .374; 95% confidence interval: .150-0.930; P < .05).

Conclusions: A lower ASPECTS-time score may predict better clinical outcomes after endovascular treatment.

Keywords: Ischemic stroke; endovascular recanalization; endovascular therapy; outcome predictive factors; revascularization.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Ischemia / diagnostic imaging*
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy*
  • Disability Evaluation
  • Endovascular Procedures* / adverse effects
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Japan
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Predictive Value of Tests
  • Recovery of Function
  • Retrospective Studies
  • Stroke / diagnostic imaging*
  • Stroke / physiopathology
  • Stroke / therapy*
  • Thrombolytic Therapy
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage
  • Tomography, X-Ray Computed*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator